Finished
Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer
NCT06454201 · Nanchang University · Updated 30 Jan 2026
- What is being tested
- robotic natural orifice specimen extraction surgery; robotic transabdominal specimen extraction surgery
- For
- Natural Orifice Specimen Extraction Surgery; Middle Rectal Cancer; Robotic; Short-term Outcomes
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 150 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Jan 2023, ends 31 Dec 2025. Registered 12 June 2024.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to evaluate the short-term outcomes of roboric natural orifice specimen extraction surgery (NOSES-II) compared to conventional assisted robotic surgery in the treatment of median rectal cancer. The main question it aims to answer is: is it safe and feasible to perform roboric natural orifice specimen extraction surgery (NOSES-II) for median rectal cancer? What are the advantages of roboric natural orifice specimen extraction surgery (NOSES-II) compared to conventional assisted robotic surgery for median rectal cancer.
Sites
- the First Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, China